Subject Predicate Object
h8ZpZ8Uy
a
Resource
Answer
Written answer
answer has question
Psy2EPpw
answer has answering person
Stephen William Hammond
answer text
<p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the UK that come from, or via, the European Union or European Economic Area asking them to ensure a minimum of 42 days additional supply in the United Kingdom, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>The Department does not hold information about the value of the medicines that will be stockpiled in either refrigerated or non-refrigerated storage. The medicines will remain the property of the suppliers who would hold that information. Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p><p> </p><p>In the light of this engagement the Department is currently considering how best it may support industry taking part in the contingency planning.</p><p> </p><p>In October, a tender process to secure the provision of additional warehouse space for stockpiled medicines covering ambient, cold chain and controlled drug storage was undertaken. Contract agreements for the procurement of storage, including refrigerated storage have recently been signed. The sum total cost of additional warehouse is expected to cost the Government in the low tens of millions of pounds.</p><p> </p><p>We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019. The storage space needs to be available for 12 months to allow for stock build and stock wind down.</p><p> </p><p>To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company or a specific medicine into the public domain.</p>
answer given date
answer has answering body
Department of Health and Social Care
written answer has answering body
Department of Health and Social Care
Department of Health and Social Care
answering body has written answer
h8ZpZ8Uy
answering body has answer
h8ZpZ8Uy
Psy2EPpw
question has answer
h8ZpZ8Uy
Stephen William Hammond
answering person has answer
h8ZpZ8Uy